Although the newly found mutations had no obvious effect on the prognosis of MCL patients, some SAMHD1 mutations previously reported were associated with chronic lymphocytic (B-cell) leukemia development (11) and changed its dNTPase activity (39). Here, SAMHD1 is linked to B-cell chronic lymphocytic leukemia.